Assisted innovator drug company in acquisition requiring expedited review of patent and exclusivity protection on lead product in Phase III trials.
-
Chair, Patent Litigation & Counseling
Assisted innovator drug company in acquisition requiring expedited review of patent and exclusivity protection on lead product in Phase III trials.